Table 3.

Echocardiographic parameters pre- and post-doxorubicin therapy for cumulative doxorubicin dose < 200 and ≥ 200 mg m^− 2

	Cumulative Doxorubicin dose (<  200 mg m− 2)			Cumulative Doxorubicin dose (≥200 mg m− 2)
	Pre	Post	P-value	Pre	Post	P-value
LVEF (%)	63.8 ± 6.9	62.9 ± 7.5	0.74	63.0 ± 5.9	60.7 ± 13.1	0.34
RV GLS	−22.6 ± 3.6	−21.3 ± 3.9	0.32	−22.3 ± 4.5	− 20.1 ± 2.9	0.03
RV FAC	47.9 ± 4.1	46.1 ± 3.9	0.18	47.0 ± 4.7	42.2 ± 3.1	0.01
RV FWS	−25.2 ± 2.8	−23.6 ± 3.4	0.13	−24.6 ± 3.6	−21.5 ± 2.4	0.01

LVEF Left ventricular ejection fraction, RVFAC Right ventricular fractional area change, RVFWS Right ventricular free wall strain, RVGLS Right ventricular global longitudinal strain